# Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

> **NCT02907827** · NA · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** follow up DW MRI

## Key facts

- **NCT ID:** NCT02907827
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907827, "Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02907827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*